UPDATE SEPTEMBER 2017: See: Government-mandated over-vaccination in Australia – Time for citizens to demand transparency and accountability.
UPDATE JUNE 2016: See my letters challenging over-vaccination policy and the No Jab, No Pay Law, forwarded to the Australian Government’s (former) Chief Medical Officer, Chris Baggoley.
VACCINES ARE BIG BUSINESS, WORTH BILLIONS OF DOLLARS ON AN INTERNATIONAL BASIS
According to international market reports, the vaccines market is increasing from US$5.7 billion in 2002 to US$49.27 billion by 2022.
So from 2002 to 2022 the vaccine market is predicted to increase more than eight-fold! This is astonishing.
And this increasingly lucrative market is receiving little or nothing in the way of independent and critical analysis…
Is all this vaccination really necessary and beneficial to individuals, or is there some very lucrative over-vaccination going on, with the sanction of governments and the medical/scientific establishment?
While a single shot of effective ‘live’ measles and rubella vaccine is reported to provide lifelong protection from these diseases, some other vaccine products are of questionable value e.g. annual flu vaccination for the ever-mutating flu, controversial HPV vaccination, and repeated ‘boosters’ with the failing pertussis vaccine.
Is the ever-increasing list of vaccine products being seen as the saviour for pharmaceutical companies facing the patent cliff?
The World Health Organisation (WHO) has indicated we are experiencing a vaccine boom. An article published in New Scientist in late 2011 says: “No longer the unprofitable runt of the pharmaceutical family, vaccines are fast becoming the industry’s breadwinner…While the rest of the pharmaceutical sector struggles to keep afloat as expiring patents send profits plummeting, the vaccine industry has become remarkably buoyant”.
In 2009, Associated Press reported: “Vaccines now are viewed as a crucial path to growth, as drug companies look for ways to offset a slowing of prescription-medicine sales amid intensifying generic competition and government pressure to restrain prices under the federal health-care overhaul”.
Vaccines are the booming new market for pharmaceutical companies, it appears the floodgates opened in the 1980s when the United States protected vaccine manufacturers from liability.
There are forces working very hard to set up a massive international vaccine market in developed and developing countries. Relationships between the vaccine industry and organisations such as the WHO, US Centers for Disease Control and Prevention (CDC), US National Institutes of Health (NIH), the GAVI Alliance, and the Bill & Melinda Gates Foundation etc need to be scrutinised.
LACK OF TRANSPARENCY AND ACCOUNTABILITY IN VACCINATION POLICY
Children are the major target for the vaccine industry’s growth, as indicated by ever-increasing national vaccination schedules. New vaccines continue to be added to vaccination schedules with an alarming lack of transparency of the process, see for example the controversial human papillomavirus (HPV) vaccine. Children who are already likely to be immune after the first dose of the Measles/Mumps/Rubella (MMR) vaccine are arbitrarily revaccinated with a second dose, often misleadingly termed a ‘booster’. In recent times adults are also being urged to have repeated vaccinations, for example annual flu vaccinations of dubious value, and recent calls for questionable ‘boosters’ with the failing whooping cough/pertussis vaccine.
Are people being properly informed about the risks and benefits of these vaccines? Is legally valid ‘informed consent’ being obtained before vaccination?
With vaccine manufacturers sizing up the potential for lucrative global vaccine markets, industry-funded ‘peer-reviewed literature’ being used to promote vaccine products, and entrepreneurial scientists lining up for vaccine royalties, there are strong vested interests to consider. There are also questions about the long-term efficacy of some vaccines, inadequately researched possible adverse reactions to vaccination, and the, in effect, limited liability of international vaccine manufacturers.
Debate on vaccination has been polarised between ‘pro’ and ‘anti’ vaccination factions, with any questioning of the vaccination status quo being regarded as taboo. There appears to be little consultation with the general public about additions to vaccination schedules, and there are concerns about potential conflicts of interest of government health advisors in this area.
The lack of transparency and accountability in the promotion of vaccine products is unacceptable. Government bodies are using coercive policies to press vaccines of questionable value on mass populations of children and adults and this must be challenged.
HUMAN VACCINATION AND COMPANION ANIMAL VACCINATION – LESSONS TO BE LEARNED
It is now taken as a given that ‘vaccination is good’, ‘vaccination is safe’, ‘you can’t have too many vaccines’. Paul Offit, Chief of the Division of Infectious Diseases and the Director of the Vaccine Education Center at the Children’s Hospital of Philadelphia, is famous for his flippant remark that a baby’s immune system could handle as many as 10,000 vaccines, and upping the ante by saying it was probably “closer to 100,000”.
Paediatrician Paul Offit’s cavalier attitude contrasts quite markedly with the more considered opinion of Ronald Schultz, Professor and Chair of the Department of Pathobiological Sciences, University of Wisconsin-Madison, and an expert in companion animal vaccines.
While Professor Schultz acknowledges that “vaccination should be considered an important medical practice” he also cautions on the over-use of vaccines: “I tell practitioners that vaccines are drugs, albeit biological drugs. I remind them that they would not consider it good medicine to give an unnecessary pharmaceutical drug on a recurring basis. I think it is even worse to give a vaccine, or biological drug, that isn’t necessary. The possible adverse consequences of a vaccine generally far outweigh the adverse consequences of a pharmaceutical drug. A pharmaceutical drug is usually much more restricted in its action. However, each time we stimulate an immune response, we have to look at the effect on all body systems—not only on antibody responses or cell-mediated immunity, but also on interactions with the endocrine system and the nervous system.”
There are interesting comparisons to be made between companion animal vaccination and human vaccination. For instance, veterinary academics and veterinarians have raised concern about over-vaccination of companion animals and its possible connection with immune-mediated hemolytic anemia, thrombocytopenia, polyarthritis, atopy, chronic allergies, asthma etc. Are there lessons here for human vaccination? For example, could there be a possible connection with over-vaccination and allergies, which have been reported to have hit “epidemic proportions“[13,14,15,16,17] in Australia, and other health problems in humans? While it may be difficult to prove a connection, surely it would be prudent to reduce unnecessary vaccination to avoid any risk?
While international dog and cat vaccination guidelines warn that we should decrease companion animal vaccination, i.e. “we should aim to reduce the ‘vaccine load’ on individual animals in order to minimize the potential for adverse reactions to vaccine products”, vaccination of humans is increasing at a startling rate.
Professor Schultz is an author of the companion animal vaccination guidelines, which acknowledge that “there is gross under-reporting of vaccine-associated adverse events, because of the passive nature of reporting schemes, which impedes knowledge of the ongoing safety of these products”. While these animal vaccination guidelines are compromised in that they are industry-funded, they are nevertheless a groundbreaking initiative, with their concept of categorising ‘core’, ‘non-core’ and ‘not recommended’ vaccines.
With the increasing number of human vaccines coming onto the market, it’s time to adopt the cautious attitude exhibited by experts in animal vaccination, and critically consider the worth of individual vaccines, and the potentially deleterious consequences of over-vaccinating humans with a multitude of vaccine products throughout life.
THE “ARROGANCE OF PREVENTIVE MEDICINE”
Considering ever-growing vaccination schedules, the thoughts of Professor Emeritus David Sackett, (a pioneer of evidence based medicine), on “the arrogance of preventive medicine” should be borne in mind, i.e.:
“But surely the fundamental promise we make when we actively solicit individuals and exhort them to accept preventive interventions must be that, on average, they will be the better for it. Accordingly, the presumption that justifies the aggressive assertiveness with which we go after the unsuspecting healthy must be based on the highest level of randomized evidence that our preventive manoeuvre will, in fact, do more good than harm. Without evidence from positive randomized trials (and, better still, systematic reviews of randomized trials) we cannot justify soliciting the well to accept any personal health intervention. There are simply too many examples of the disastrous inadequacy of lesser evidence as a basis for individual interventions among the well: supplemental oxygen for healthy premies (causing retrolental fibroplasia), healthy babies sleeping face down (causing SIDS), thymic irradition in healthy children, and the list goes on.”  (Emphasis added.)
Also consider Professor Schultz’s warning that: “Vaccines are medical products that should only be given if needed and only as often as is necessary to provide protection from diseases that are a risk to the health of the animal. If a vaccine that is not necessary causes an adverse reaction that would be considered an unacceptable medical procedure, thus use only those vaccines that are needed and use them only as often as needed.”
VACCINATION RECOMMENDATIONS MUST BE TRANSPARENTLY EVIDENCE-BASED
Aggressive marketing by the pharmaceutical industry and industry-affiliated ‘experts’, including lobbying for compulsory vaccination with vaccines of dubious value (e.g. HPV and annual flu vaccines), is threatening citizens’ autonomy.
It’s time there was an investigation into the relationships between governments, the vaccine industry, and the industry’s handmaidens in the scientific/medical establishment, but who can we trust to do that? The mainstream media has generally been completely useless on this matter, and incapable of providing critical analysis, merely supporting the status quo.
Where are the whistleblowers?
Citizens must be allowed to have a rational debate on this important subject to ensure public confidence in vaccination practice. All vaccination recommendations must be transparently evidence-based.
FOR MORE CRITICAL ANALYSIS OF THE VACCINE INDUSTRY SEE:
- conflicts of interest…and vax committees
- controversial Human Papillomavirus (HPV) vaccination;
- the arbitrary Measles/Mumps/Rubella (MMR) second ‘booster’ dose;
- annual flu vaccination and the influenza industry;
- pertussis / whooping cough – how does increasing the numbers of ‘boosters’ of the current vaccine protect against the new strain?;
- aluminium and vaccine safety
- ‘Gain of function’ research and the influenza industry
- over-vaccination of pets – an unethical practice;
References: (Links current as at 3 May 2013.)
 A recent vaccines market report notes the global vaccines market is expected to reach US$49.27 billion by 2022 from US$34.30 billion in 2017. A FierceVaccines report published in 2012 notes ten years previously, the vaccine market sat at US$5.7 billion. Now , that market has soared to US$27 billion. So it seems from 2002 to 2022 the vaccines market will increase from US$5.7 billion to US$49.27 billion.
References: MarketsAnd Markets Press Release: Vaccine Market worth 49.27 Billion USD by 2022 (undated), and FiercePharma report 20 Top-selling Vaccines – H1 2012, 25 September 2012.
 “…big companies were also buying up smaller medical firms and diversifying their product ranges to protect themselves from “significant sales losses”. GlaxoSmithKline, Britain’s biggest drug maker, has already broadened its portfolio to include vaccines and consumer healthcare, for example.” Big Pharma won’t fall off a patent cliff, says S&P. The Telegraph, 18 December 2012.
 State of the world’s vaccines and immunization. WHO, UNICEF, World Bank. 3rd ed. Geneva, World Health Organzation, 2009.
 Vaccines enjoy a healthy return. NewScientist, 28 September 2011.
 Vaccines become drugmakers’ profit boosters. Pharmaceutical companies drawn to development of vaccines for variety of diseases. The Columbus Dispatch, 30 November 2009.
 See for example The top 5 vaccine makers by 2014 revenue, FierceVaccines, 13 August 2015: http://www.fiercevaccines.com/special-reports/top-5-vaccine-makers-2014-revenue and Expect vaccines market to swell to $40B by 2020: Tufts CSDD, FierceVaccines, 16 July 2015: http://www.fiercevaccines.com/story/expect-vaccines-market-swell-40b-2020-tufts-csdd/2015-07-16 My webpage Over-vaccination – A Multi-Billion Dollar Market also provides some background: https://over-vaccination.net/over-vaccination-a-multi-billion-dollar-market/
 The US National Vaccine Injury Compensation Program was established to protect vaccine manufacturers from direct liability: http://www.hrsa.gov/vaccinecompensation/index.html Also see Feds Vows to Publicize Vaccine Injury Help Program, The New York Times, 21 November 2014. This AP article is still available online via the UK Daily Mail: http://www.dailymail.co.uk/wires/ap/article-2844694/Feds-vows-publicize-vaccine-injury-help-program.html
 Australian National Immunisation Program Schedule from 1 February 2013 to 30 June 2013 and Australian National Immunisation Program Schedule from 1 July 2013; the United Kingdom NHS Vaccination Schedule; the United States Birth-18 Years & “Catch-up” Immunization Schedules, 2013 and Adult Immunization Schedules, 2013.
 Pharma conflicts must be disclosed. The Australian, 25 June 2012.
 Stomping Through a Medical Minefield. Newsweek Magazine, 24 October 2008. Also published in The Indian Express 16 November 2008.
 Titer Testing And Vaccination: A New Look at Traditional Practices. A Roundtable Discussion. Veterinary Healthcare Communications, 2002.
 Child allergy rates at ‘epidemic proportions’. Sydney Morning Herald, 9 March 2010.
 Chain reaction – In less than a generation, food allergies in children – some of them potentially fatal – have reached epidemic levels. GoodWeekend, 23 July 2011.
 Kemp, AS, Mullins, RJ, Weiner, JM. The allergy epidemic: what is the Australian response? Medical Journal of Australia. Vol. 185, No. 4, 21 August 2006.
 Food Allergy. The Health Report, ABC Radio National, 30 May 2011.
 HealthNuts Research Update 2011. Murdoch Children’s Research Institute.
 M.J. Day, M.C. Horzinek, R.D. Schultz and R.A. Squires. Guidelines for the Vaccination of Dogs and Cats. Journal of Small Animal Practice. Vol. 57, June 2016.
 Sackett, D. The arrogance of preventive medicine. CMAJ. Aug. 20, 2002; 167 (4) 363-364.
 Schultz, Ron. What Everyone Needs to Know About Canine Vaccines and Vaccination Programs.
Disclaimer: The purpose of this website is to provoke discussion on vaccination practice. Readers are encouraged to do their own research on this topic to support any decisions regarding vaccination.